These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16967613

  • 21. The role of DMARDs in systemic sclerosis therapy.
    Blank N, Max R, Lorenz HM.
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii42-4. PubMed ID: 16987834
    [Abstract] [Full Text] [Related]

  • 22. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
    Diot E, Valat C, Boissinot E, Giraudeau B, Asquier E, Guilmot JL, Lemarié E, Diot P.
    Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
    [Abstract] [Full Text] [Related]

  • 23. Advanced systemic sclerosis complicated by pulmonary hypertension and complete atrioventricular block: a case report.
    Ciurzyński M, Bienias P, Szewczyk A, Lichodziejewska B, Błaszczyk M, Liszewska-Pfejfer D, Pruszczyk P.
    Med Sci Monit; 2007 Oct; 13(10):CS124-7. PubMed ID: 17901856
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Targeted therapy for systemic sclerosis.
    Steen V.
    Autoimmun Rev; 2006 Feb; 5(2):122-4. PubMed ID: 16431341
    [Abstract] [Full Text] [Related]

  • 27. Care of patients with scleroderma in the intensive care setting.
    Farber HW, Simms RW, Lafyatis R.
    J Intensive Care Med; 2010 Sep; 25(5):247-58. PubMed ID: 20542965
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Systemic sclerosis in childhood].
    Falcini F, Trapani S, Taccetti G, Tafi L.
    Pediatr Med Chir; 1990 Sep; 12(6):593-9. PubMed ID: 2093880
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P, Medsger TA, Morel PA.
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
    Herbai G.
    Acta Med Acad Sci Hung; 1978 Apr; 35(3-4):201-11. PubMed ID: 756110
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Renal involvement in scleroderma].
    Boffa JJ, Rossert J.
    Rev Prat; 2002 Nov 01; 52(17):1910-4. PubMed ID: 12532868
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis.
    Allanore Y, Seror R, Chevrot A, Kahan A, Drapé JL.
    Arthritis Rheum; 2007 Aug 01; 56(8):2747-54. PubMed ID: 17665441
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.